TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 94 filers reported holding TERNS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,017,810 | -42.5% | 202,348 | 0.0% | 0.31% | +0.3% |
| Q2 2023 | $1,770,545 | -26.1% | 202,348 | 0.0% | 0.31% | -37.2% |
| Q1 2023 | $2,395,800 | +16.3% | 202,348 | 0.0% | 0.50% | +11.7% |
| Q4 2022 | $2,059,903 | +21.0% | 202,348 | -30.0% | 0.44% | +11.6% |
| Q3 2022 | $1,703,000 | +137.5% | 289,068 | 0.0% | 0.40% | +107.9% |
| Q2 2022 | $717,000 | -16.5% | 289,068 | 0.0% | 0.19% | -11.6% |
| Q1 2022 | $859,000 | -58.0% | 289,068 | 0.0% | 0.22% | -45.6% |
| Q4 2021 | $2,044,000 | -32.1% | 289,068 | 0.0% | 0.40% | -16.1% |
| Q3 2021 | $3,012,000 | -15.0% | 289,068 | 0.0% | 0.47% | +8.2% |
| Q2 2021 | $3,544,000 | -67.6% | 289,068 | -41.9% | 0.44% | -78.4% |
| Q1 2021 | $10,946,000 | – | 497,555 | – | 2.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,657,992 | $33,489,700 | 3.67% |
| ACUTA CAPITAL PARTNERS, LLC | 555,260 | $2,792,958 | 1.87% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,041,910 | $30,390,807 | 1.64% |
| VR Adviser, LLC | 3,092,273 | $15,554,133 | 1.64% |
| Fairmount Funds Management LLC | 2,040,000 | $10,261,200 | 1.24% |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $3,592,854 | 1.20% |
| Deep Track Capital, LP | 6,000,000 | $30,180,000 | 1.16% |
| Orbimed Advisors | 7,619,135 | $38,324,249 | 0.81% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 500,000 | $2,515,000 | 0.76% |
| GREAT POINT PARTNERS LLC | 645,899 | $3,248,872 | 0.59% |